Not here to pump, or to blow smoke up people's a $ $ like you and so many others. people who post have agendas I don't just to post the facts and truth. Sorry if you can't handle it.
GLTY . Your time would be better spent writing to management
I could give you dozens of reason and you are obviously new and have not been involved as long as I. I'll keep it to a few
Management has zero credibility, they have promised to address the #1 issue which they have yet to do which is the balance sheet,
Cellution 2 machine delayed
No revenue from Japan as promised
No orders from KT or revenues from China as promised after approval of law there which has happened
Barda has not delivered $'s as promised after approval to move forward
No use of technology in Europe where it has been approved for years
Manipulation by the shorts
No meaningful insider buying. If management doesn't believe in themselves why should investors
Shall, I continue ?
You answered your own question. There reputations stink and investors who have followed the anaysts are in the toilet. They are just part of the scam. I can't believe I have let myself be Calhouned again. This whole thing just makes me sick and actually thinking that this wiuld turn around is just insanity. Shame on me.
Again, You clearly do not understand the new marketing strategy of Cytori. It is no longer about selling consumables or machines as per the FDA Cytori will be selling the stem cells. This is how the FDA can regulate in the USA. Outside USA yes they will sell machines and consumables perhaps one day when cellution 2 is ready for market.
Cytori is moving ADRCs (Adipose-derived regenerative cells) closer to entering the clinic for thermal burn and radiation exposure with data presented at the 2015 meeting of the American Burn Association this week in Chicago. Cytori made two presentations.
The first showed preclinical evidence of accelerated wound healing with increased blood vessel density, collagen deposition and epithelialization (skin) using large animal models of thermal burns and radiation exposure.
This is the first large animal model that reflects the clinical situation of patients exposed to thermal and radiation injury. (ABSTRACT LINK)
The second presentation showed improved dermal regeneration, vascularization and structural organization of thermal burn injuries over control when ADRCs were seeded onto a collagen scaffold. (ABSTRACT LINK)
Conclusion: These data put Cytori closer to the clinic. If the company can get to the clinic, the BARDA contract is structured to add $8M of funding for the first trial, beyond which there are options for additional work in thermal burns complicated by radiation exposure; combined value of $68M. ADRCs are also being evaluated in a pivotal study for scleroderma.
Thermal Burns and BARDA. The BARDA contract is worth up to $106M in non-dilutive capital. The contract with BARDA is now worth $14.1M with the additional $2M added on December 19, 2014. This funds Cytori through pilot studies and planning of an initial clinical trial for thermal burns. If successful in preclinical studies, and with approval of an IDE, another $8M will be added onto the contract to fund a clinical trial. The company anticipates completing the trial following the release of the next-generation Celution system in 2015. The contract also has two options valued at $45M and $23M that could fund a pivotal trial and additional work in thermal burns complicated by radiation exposure. The path through clinical development for ADRCs in thermal burns has the potential to be more rapid than we previously thought as we have now seen the ADRC Celution System given a pathway to approval that includes running only a modest-sized phase II/III pivotal clinical trial in scleroderma.
Adipose-Derived Stem and Regenerative Cells; is fat good? ADRCs, as the name implies, are derived from fat. A key publication describing how ADRCs are characterized after being isolated from adipose tissue with the Celution System was published in 2008 (Lin et al.'Characterization of adipose tissue-derived cells isolated with the celution system', Cytotherapy (2008), Vol. 10, Nov 4). Yes, fat tissue has cells with broad regenerative medicine potential. In fact, adipose tissue is the richest known source of adult stem cells. When you compare that adipose tissue containing 2-5% regenerative cells (ADRCs) to 0.0004% regenerative cells in the same person’s bone marrow, it’s a significant difference. Cytori isolates ADRCs using the ‘Celution System’ which is an automated process that can deliver autologous, point-of-care regenerative cell therapy with minimal handling and manipulation, the latter contributing to low cost of goods sold for the company. Additional indications include thermal burns, scleroderma, stress urinary incontinence, osteoarthritis and acute myocardial infarction.
Valuation. We assume Cytori will be successful in Scleroderma and multiple other indications utilizing ADRCs (thermal burns, stress urinary incontinence, and osteoarthritis. We apply a 25% risk cut to our therapeutic model and a 30% discount to financial models for FCFF, discounted EPS, and SOP to arrive at a $6.00 PT.
No it is not but actually monetizing it and getting partners seems to be a hrdle they have yet to be able to overcome. You can't eat potential.
So Lim robbed Peter to Pay Paul. Why set up a website if nothing to tell. Credibility remains the issue with Cytori. Hedrik no different from CC. The incompetence continues. This joke of a company is not at all funny.
Bottom line is that nobody here has the answer,nor should they be forced to speculate, however, that is just the way Cytori operates. One minute KT is to quote Dr. Hedrik fogging his glasses the next minute he is selling shares. Perhaps the answer is that during next round of financing he buys at .57 and gets more bang for his buck. So much for transparency and better communication with shareholders . This has become a very bad joke and my worst nightmare certainly not 10x's wildest dreams.
Nice article, wonder why no mention of the supposed leader in the stem cell space cytori theraputics. The news just keeps getting better for us stuck holders.
Rodney, Don'texpect any news from Cytori nor any change in the way this company operates. I regret the day I was introduced to this company some 5 years ago. Unfortunately this has been a very expensive lesson. The shorts will win again as dilution will come as company needs money and management has proven that they can't secure a partnership nor raise money unless they go to loan sharks . I don't believe this company will ever become what we all thought the potential promised. 10x'smy wildest dreams has become my worst nightmare. I would be thrilled to break even but owning shares @an average of $5.20 I don't see that happening any time soon and with each passing day my hopes fade. I wish I could believ that $ cost averaging would be prudent but I don't see it.
If there was a new presentation to be seen on the lorem website that would be news, but as of now still the same single page that has been up there for two years with no information. Not so exciting or informative, true to form.
Everyone wants to blame AF. Yes he speaks half truths and outright lies but Cytori management has put us in this most precarious position not AF. Anger and displeasue should be focused where it belongs not on a messeger with an agenda. Time for some real change at Cytori and how about an update on Lorem Vascular that actually gives shareholders some facts. Hedrik promised transparency guess he spells it like Obama does.
Rodney with all respect to WST he has been wrong about Cytori for years as has everyone else who continues to make excuses for this mismanaged ,non revenue generating company. Hedrik is not the man to lead us to the promised land. Cash is an issue and has been #1 issue he has comitted to solve but here we sit. Sorry but no longer believing the BS and only execution will change my mind. Been Calhouned enough. Cytori gives AF the ammo to post his drivel and do what he is paid to do and that is to make money for the shorts.Sorry to be so negative but this POS has cost me way to much money and I my patience is long gone.GLTA
That page has been up there with no change since the day the deal with Cytori was announced what almst 3 years ago now. I signed up for additional imnfo on that day and not a peep. Nothing has changed at cytori in my eyes other then some of the bad managers were fired. Our current CEO was just as respondsible for the failure of this company todate as was Chris calhoun. All talk no action, and by his own admission Hedriks #1 priority to fix the balance sheet is nowhere and the company has been given away to loan sharks. I'm tired of people defending what is indefenseable. The shorts have been right and the only ones who have made money on this stock and continue to do so. I would also warn you that some of those who post particularly on Fas board and claim to be longs, may have benefited handsomely from the drop in PPS as well. Wolf in sheeps clothing so to speak. I say enough BS, execute.
Rodney it is you who are missing the point and lack understanding of what has transpired over the last 10 + years. Adam F would not have the ammunition he does nor the success if Cytori was a well run compant that was buttomed up. The throw up up against the wall and see wghat sticks approach is why the 200 million plus that has been spen on R&D has netted shareholders zero. If you are so shortsighted that you can't understand how foolish it looks to have no presense on the internet after 3 years, I can't help you.
I have done battle with AF before. he is a paid shill, and will do all that he can to help his short buddies. This is what he does. He knows he is a #$%$ and is proud of it. Hebashed a company some years ago called medarex, saying products were worthless. medarex was bought by Brystal meyers and has the leading cancer drug in the BMY stable of cancer drugs. No validity to what he wrote about company but he was successful in helping the shorts. This is what he does, same as his boss Mr. Cramer